AtaiBeckley (ATAI) Change in Cash (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Change in Cash of -$42.2 million for Q1 2026, down 237.09% year-over-year from $30.8 million in Q1 2025, and down 237.09% quarter-over-quarter from $30.8 million in Q1 2025.
Analysis
AtaiBeckley (ATAI) Change in Cash (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Change in Cash for 6 years, with the latest figure at -$31.5 million in Q3 2025.
- Quarterly Change in Cash fell 396.69% year-over-year to -$31.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$14.6 million (up 53.82% YoY) and the FY2024 annual result came in at -$17.5 million, up 87.96% from the prior year.
- Change in Cash for Q1 2026 stood at -$42.2 million, down from $30.8 million in the prior quarter.
- The five-year high for Change in Cash was $30.8 million in Q1 2025, with the low at -$42.2 million in Q1 2026.
- A 5-year average of -$3.5 million and a median of -$11.2 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash sank 3445.37% in 2022, then soared 685.59% in 2025.
- Over 5 years, Change in Cash stood at -$68.0 million in 2021, then soared by 170.65% to $48.1 million in 2022, then sank by 165.44% to -$31.5 million in 2023, then surged by 44.5% to -$17.5 million in 2024, then sank by 80.65% to -$31.5 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$31.5 million, $3.7 million, and $30.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | -31.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.71 Mn |
| Mar 31, 2026 | -42.20 Mn |
| Sep 30, 2025 | -31.54 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Dec 31, 2024 | -17.46 Mn |
| Sep 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | -11.17 Mn |
| Dec 31, 2023 | -31.46 Mn |
| Sep 30, 2023 | -64.60 Mn |
| Jun 30, 2023 | -44.80 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | 48.07 Mn |
| Sep 30, 2022 | 58.41 Mn |
| Jun 30, 2022 | -39.84 Mn |
| Mar 31, 2022 | -238.29 Mn |
| Dec 31, 2021 | -68.04 Mn |